BioXcel Holdings, Inc., 10% Owner, CEO and President at BioXcel Therapeutics, Inc. (BTAI), sold 504,056 shares at $1.58 ($809K) on 2024-06-05, disclosed to the SEC on 2024-06-06.
Open-market sale of $809k BTAI by 10% Owner, CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.63 | 126,014 | $205K | 25.4% |
| 2 | $1.63 | 126,014 | $205K | 25.4% |
| 3 | $1.58 | 126,014 | $199K | 24.6% |
| 4 | $1.58 | 126,014 | $199K | 24.6% |
| Total | $1.61 avg | 504,056 | $809K | 100% |